SCHEMBL31290959

SCHEMBL31290959

Cc1c(F)cc(N)cc1-c1nc(N2CCOCC2)c2sccc2n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 11/20 0.60
MTOR P42345 7/20 0.60
PIK3R1 P27986 2/20 0.52
PIK3CB P42338 3/20 0.52
PIK3CG P48736 3/20 0.52
PIK3C2B O00750 1/20 0.52
CCNE2 O96020 1/20 0.52
PRKACA P17612 1/20 0.52
PRKACG P22612 1/20 0.52
PRKACB P22694 1/20 0.52
CCNE1 P24864 1/20 0.52
CDK2 P24941 1/20 0.52
KDR P35968 1/20 0.52
KDM4E B2RXH2 1/20 0.51
RAF1 P04049 3/20 0.48
BRAF P15056 2/20 0.48
PIKFYVE Q9Y2I7 1/20 0.44
PIK3CD O00329 3/20 0.43
PDGFRB P09619 1/20 0.42
KIT P10721 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24885831 1.00 PIK3CA (0.60) PIK3CAMTORPIK3R1PIK3CBPIK3CG
SCHEMBL24885920 0.86 RAF1 (0.53) PIK3CAMTORPIK3R1PIK3CBPIK3CG
SCHEMBL24885806 0.84 PIK3CA (0.67) PIK3CAMTORPIK3R1PIK3CBPIK3CG
SCHEMBL30078287 0.84 PIK3CA (0.67) PIK3CAMTORPIK3R1PIK3CBPIK3CG
SCHEMBL1864574 0.80 PIK3CA (0.63) PIK3CAMTORPIK3R1PIK3CBPIK3CG
SCHEMBL1858784 0.78 PIK3CA (0.66) PIK3CAMTORPIK3R1PIK3CBPIK3CG
SCHEMBL4440860 0.77 PIK3CA (0.74) PIK3CAMTORPIK3R1PIK3CBPIK3CG
SCHEMBL24885730 0.76 PIK3CA (0.73) PIK3CAMTORPIK3R1PIK3CBPIK3CG
SCHEMBL4436841 0.75 PIK3CA (1.00) PIK3CAMTORPIK3R1PIK3CBPIK3CG
SCHEMBL12110480 0.73 PIK3CA (0.72) PIK3CAMTORPIK3R1PIK3CBPIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400577-A1 MODULATORS OF PROTEIN KINASES VIBLIOME THERAPEUTICS, LLC 2024-12-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240400577-A1 MODULATORS OF PROTEIN KINASES MAP3K20, PRKCE, PRKCH PIK3CA 218/4885MTOR 160/4885PIK3R1 341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.